Sumitomo Mitsui Trust Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$156 Billion
Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 655,050 shares of VRTX stock, worth $268 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

655,050

Previous 643,987 1.72%

Holding current value

$268 Million

Previous $312 Million 6.59%

% of portfolio

0.19%

Previous 0.23%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$421.16 - $509.5 $4.66 Million - $5.64 Million	11,063 Added 1.72%	655,050 $292 Million
Q1 2025 Apr 25, 2025	SELL	$402.49 - $513.76 $6.26 Million - $7.99 Million	-15,546 Reduced 2.36%	643,987 $312 Million
Q4 2024 Jan 28, 2025	SELL	$396.64 - $516.74 $4.98 Million - $6.49 Million	-12,565 Reduced 1.87%	659,533 $266 Million
Q3 2024 Nov 05, 2024	BUY	$460.0 - $505.78 $3.09 Million - $3.4 Million	6,716 Added 1.01%	672,098 $313 Million
Q2 2024 Jul 19, 2024	SELL	$392.81 - $485.53 $20.8 Million - $25.7 Million	-53,028 Reduced 7.38%	665,382 $312 Million
Q1 2024 Apr 19, 2024	BUY	$407.69 - $446.08 $3.18 Million - $3.48 Million	7,794 Added 1.1%	718,410 $300 Million
Q4 2023 Jan 30, 2024	SELL	$343.0 - $410.68 $332,024 - $397,538	-968 Reduced 0.14%	710,616 $289 Million
Q3 2023 Oct 30, 2023	SELL	$338.18 - $362.46 $3.54 Million - $3.79 Million	-10,457 Reduced 1.45%	711,584 $247 Million
Q2 2023 Jul 31, 2023	SELL	$314.42 - $351.91 $38.7 Million - $43.4 Million	-123,186 Reduced 14.57%	722,041 $254 Million
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $2.74 Million - $3.13 Million	-9,681 Reduced 1.13%	845,227 $266 Million
Q4 2022 Jan 30, 2023	SELL	$285.76 - $321.48 $23.2 Million - $26.1 Million	-81,147 Reduced 8.67%	854,908 $247 Million
Q3 2022 Oct 21, 2022	BUY	$273.83 - $305.53 $2.12 Million - $2.37 Million	7,748 Added 0.83%	936,055 $271 Million
Q2 2022 Jul 26, 2022	SELL	$234.96 - $292.55 $11.1 Million - $13.8 Million	-47,077 Reduced 4.83%	928,307 $262 Million
Q1 2022 Apr 27, 2022	SELL	$221.42 - $260.97 $14.3 Million - $16.8 Million	-64,362 Reduced 6.19%	975,384 $255 Million
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $9.26 Million - $11.7 Million	-52,295 Reduced 4.79%	1,039,746 $228 Million
Q3 2021 Oct 25, 2021	SELL	$181.39 - $202.99 $4.86 Million - $5.44 Million	-26,817 Reduced 2.4%	1,092,041 $198 Million
Q2 2021 Aug 02, 2021	SELL	$187.49 - $221.1 $25.4 Million - $29.9 Million	-135,375 Reduced 10.79%	1,118,858 $226 Million
Q1 2021 Apr 30, 2021	SELL	$207.02 - $241.31 $6.97 Million - $8.12 Million	-33,649 Reduced 2.61%	1,254,233 $270 Million
Q4 2020 Feb 05, 2021	SELL	$207.01 - $276.09 $6.23 Million - $8.3 Million	-30,077 Reduced 2.28%	1,287,882 $304 Million
Q3 2020 Oct 30, 2020	SELL	$255.65 - $303.1 $4.22 Million - $5 Million	-16,501 Reduced 1.24%	1,317,959 $359 Million
Q2 2020 Jul 27, 2020	BUY	$225.48 - $295.8 $8.17 Million - $10.7 Million	36,251 Added 2.79%	1,334,460 $387 Million
Q1 2020 Apr 27, 2020	BUY	$199.77 - $247.81 $11.2 Million - $13.9 Million	56,113 Added 4.52%	1,298,209 $309 Million
Q4 2019 Jan 31, 2020	BUY	$166.71 - $223.91 $3.45 Million - $4.63 Million	20,672 Added 1.69%	1,242,096 $272 Million
Q3 2019 Oct 31, 2019	BUY	$166.23 - $187.09 $11.4 Million - $12.8 Million	68,293 Added 5.92%	1,221,424 $207 Million
Q2 2019 Jul 29, 2019	BUY	$164.61 - $190.37 $8.31 Million - $9.61 Million	50,477 Added 4.58%	1,153,131 $211 Million
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $5.03 Million - $5.98 Million	30,705 Added 2.86%	1,102,654 $203 Million
Q4 2018 Feb 06, 2019	BUY	$151.91 - $192.21 $25 Million - $31.6 Million	164,403 Added 18.12%	1,071,949 $173 Million
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $2.89 Million - $3.32 Million	17,232 Added 1.94%	907,546 $175 Million
Q2 2018 Aug 01, 2018	BUY	$145.72 - $169.96 $12.1 Million - $14.1 Million	83,121 Added 10.3%	890,314 $151 Million
Q1 2018 May 01, 2018	SELL	$151.6 - $177.13 $29,562 - $34,540	-195 Reduced 0.02%	807,193 $132 Million
Q4 2017 Feb 06, 2018	BUY	$137.28 - $155.55 $3.07 Million - $3.47 Million	22,338 Added 2.85%	807,388 $121 Million
Q3 2017 Nov 07, 2017	BUY	$148.13 - $162.24 $1.19 Million - $1.31 Million	8,064 Added 1.04%	785,050 $119 Million
Q2 2017 Aug 07, 2017	BUY	N/A	776,986	776,986 $100 Million

Others Institutions Holding VRTX

# of Institutions

1,788

Shares Held

239M

Call Options Held

1.95M

Put Options Held

1.14M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History